Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-26 @ 6:13 PM
Study NCT ID:
NCT00035334
Status:
COMPLETED
Last Update Posted:
2006-02-14
First Post:
2002-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Sponsor:
Bellus Health Inc. - a GSK company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL-503004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |